A cheap, widely available painkiller used to treat conditions like arthritis can significantly reduce RSV in the human respiratory tract, an early-stage laboratory study suggests.
Respiratory syncytial virus (RSV) is the number one reason infants end up in the hospital in the U.S., with babies under 6 months old facing the highest risk of severe disease and death from RSV. It’s also a serious health risk for adults over 65.
Currently, there are vaccines approved for pregnant people and older adults, as well as antibody-based drugs for children that can help prevent RSV infection. But there’s no specific antiviral drug to treat the disease once someone is infected.
In the new study, published May 7 in the journal Virus Research, researchers found that the antiinflammatory drug indomethacin interferes with a key protein that RSV needs to invade human cells and spread. The finding hints…